Study on safety evaluation of Ginkgo Leaf Dripping Pill

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPN-17014067

Enrollment

Unknown

Registered

2017-12-20

Start date

2016-06-01

Completion date

Unknown

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease stable angina pectoris.cerebral infarction

Interventions

Case series:Ginkgo Leaf Dripping Pill treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: From June 2016 to June 2018, patients who take at least 1 time of Ginkgo leaf dripping pills in the outpatient or inpatient department of the research institutes.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Adverse reaction;	—

Countries

China

Contacts

Public ContactZhongqi Yang

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

yang_zhongqi@163.com+86 020-36598909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026